Close

Tag: Coronavirus information (COVID-19)

C2 PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment

C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks...

Quidel’s Lyra SARS-CoV-2 Assay Receives Authorization for Expanded Use for Molecular Detection of COVID-19

Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel’s Lyra® SARS-CoV-2 Assay...

MIG USA, a North Carolina Company, to Bring Needed Relief Through the Provision of Coronavirus Test Kits

MIG USA, LLC , a High Point, North Carolina company having focus in the biotechnology, pharmaceutical, and clinical research sectors, along with its corporate...

FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced that the U.S. FDA has provided Emergency Use Authorization (EUA) for...

Vir Biotechnology Proceeding with Two Clinical Development Candidates for COVID-19

Vir Biotechnology, Inc announced that it has identified multiple human monoclonal antibody (mAb) development candidates that neutralize SARS-CoV-2, the virus responsible for COVID-19. “We are...

OliX Pharmaceuticals Advances RNAi Approaches to Target Highly Conserved Regions of Coronavirus RNAs

OliX Pharmaceuticals, Inc. , a leading developer of RNA interference (RNAi), announced that it will leverage previous preclinical research for developing siRNA therapeutics in...

PayCargo launches communication mechanism to meet Covid-19 supply chain challenges

Online payment company PayCargo has launched a free communication mechanism that allows vendors such as airlines, ship terminals, and maritime operators to share key...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read